Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 5/20 | 0.51 |
| ▸ | CA2 | P00918 | 5/20 | 0.51 |
| ▸ | CA9 | Q16790 | 5/20 | 0.51 |
| ▸ | GAPDH | P04406 | 2/20 | 0.50 |
| ▸ | HRAS | P01112 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.41 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14428974 | 0.90 | MEN1 (0.52) | MEN1USP2POLBKMT2ACA1 | |
| SCHEMBL12300349 | 0.84 | LMNA (0.47) | MEN1USP2POLBKMT2ACA1 | |
| SCHEMBL11655632 | 0.83 | MEN1 (0.55) | MEN1USP2POLBKMT2ACA1 | |
| SCHEMBL13352083 | 0.83 | LMNA (0.55) | CA1CA2CA9ALDH1A1CA12 | |
| SCHEMBL3314328 | 0.83 | LMNA (0.55) | CA1CA2CA9ALDH1A1CA12 | |
| SCHEMBL13320635 | 0.83 | LMNA (0.55) | CA1CA2CA9ALDH1A1CA12 | |
| SCHEMBL5718816 | 0.83 | LMNA (0.55) | CA1CA2CA9ALDH1A1CA12 | |
| SCHEMBL5718815 | 0.83 | LMNA (0.55) | CA1CA2CA9ALDH1A1CA12 | |
| SCHEMBL3314337 | 0.83 | LMNA (0.55) | CA1CA2CA9ALDH1A1CA12 | |
| SCHEMBL16199375 | 0.81 | LMNA (0.44) | MEN1USP2POLBKMT2ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6660854-B2 | Reacting a 1,2,4-triazole-3-carboxylate and beta-D-ribo furanosyl-1,2,3,5-tetraacetate in the presence of a catalyst | YUHAN CORPORATION (KR) | 2003-12-09 | — | — | US | disclosed |
| US-20030120064-A1 | Processes for preparing beta-D-ribofuranose derivatives | YUHAN CORPORATION (KR) | 2003-06-26 | — | — | US | disclosed |
| US-RE29835-E | PHARMACEUTICAL | ICN PHARMACEUTICALS (US) | 1978-11-14 | — | — | US | disclosed |
| US-3984396-A | VIRICIDES | ICN PHARMACEUTICALS, INC. (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030120064-A1 | Processes for preparing beta-D-ribofuranose derivatives | UMPS, SBDS, SAMHD1 | MEN1 4683/4885USP2 2826/4885POLB 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.